Exposure

R H Lerman¹

¹Henry Ford Health System, Division of Geriatrics, Detroit, Michigan, USA.

Cancer

|May 23, 2000

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The macrobiotic diet in cancer.

The Journal of nutrition·2001

Same author

Prediction of oxygen uptake and energy expenditure during exercise in obese women.

Journal of cardiopulmonary rehabilitation·1996

Same author

Very low-fat diets for coronary heart-disease: perhaps, but which one?

JAMA·1996

Same author

The effect of low-fat diet on lipid levels.

JAMA·1996

Same author

Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders.

Metabolism: clinical and experimental·1996

Same author

Role of essential fatty acids: dangers in the US Department of Agriculture dietary recommendations ("pyramid") and in low-fat diets.

The American journal of clinical nutrition·1994

Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026

Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026

Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026

Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026

Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026

Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026

See all related articles

Related Experiment Videos

Exposure

Related Concept Videos

The macrobiotic diet in cancer.

Prediction of oxygen uptake and energy expenditure during exercise in obese women.

Very low-fat diets for coronary heart-disease: perhaps, but which one?

The effect of low-fat diet on lipid levels.

Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders.

Role of essential fatty acids: dangers in the US Department of Agriculture dietary recommendations ("pyramid") and in low-fat diets.

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Toward exercise as standard care for older cancer survivors.

Maintenance therapy in gynecologic malignancies: Current and future state.

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Related Experiment Videos

Exposure

Related Concept Videos

The macrobiotic diet in cancer.

Prediction of oxygen uptake and energy expenditure during exercise in obese women.

Very low-fat diets for coronary heart-disease: perhaps, but which one?

The effect of low-fat diet on lipid levels.

Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders.

Role of essential fatty acids: dangers in the US Department of Agriculture dietary recommendations ("pyramid") and in low-fat diets.

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Toward exercise as standard care for older cancer survivors.

Maintenance therapy in gynecologic malignancies: Current and future state.

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Related Experiment Videos

Exposure

Related Concept Videos

Related Articles

The macrobiotic diet in cancer.

Prediction of oxygen uptake and energy expenditure during exercise in obese women.

Very low-fat diets for coronary heart-disease: perhaps, but which one?

The effect of low-fat diet on lipid levels.

Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders.

Role of essential fatty acids: dangers in the US Department of Agriculture dietary recommendations ("pyramid") and in low-fat diets.

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Toward exercise as standard care for older cancer survivors.

Maintenance therapy in gynecologic malignancies: Current and future state.

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Related Experiment Videos

Exposure

Related Concept Videos

Related Articles

The macrobiotic diet in cancer.

Prediction of oxygen uptake and energy expenditure during exercise in obese women.

Very low-fat diets for coronary heart-disease: perhaps, but which one?

The effect of low-fat diet on lipid levels.

Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders.

Role of essential fatty acids: dangers in the US Department of Agriculture dietary recommendations ("pyramid") and in low-fat diets.

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Toward exercise as standard care for older cancer survivors.

Maintenance therapy in gynecologic malignancies: Current and future state.

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.